FIB991
Asset
Blocks the YAP/TAZ pathway, shutting down fibroblast activation and stopping fibrosis progression.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2ADPKD
Preclinical, fibrocor.com, 10 Oct 2026
Kidney allograft fibrosis
Preclinical, fibrocor.com, 10 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.